This study aimed to explore the influence of pyrazinamide (PZA) monoresistance on the treatment outcome of otherwise drug susceptible tuberculosis (TB). A cohort of 194 TB patients that were infected with strains susc...This study aimed to explore the influence of pyrazinamide (PZA) monoresistance on the treatment outcome of otherwise drug susceptible tuberculosis (TB). A cohort of 194 TB patients that were infected with strains susceptible to isoniazid (INH), rifampin (RIF) and ethambutol (EMB) were included in a retrospective study at the Guangzhou Chest Hospital. We reported 148 (76.3%) PZA- susceptible TB cases and 46 (23.7%) PZA-monoresistance TB cases identified by the BACTEC MGIT 960 system. All patients were treated with the standard 6 months WHO recommended regimen, which included 2 months of INH + RIF + EMB + PZA in the intensive-phase, and the subsequent 4 months of INH + RIF during continuation-phase. Bacterial burden in the lungs was estimated using sputum smear acid-fast bacillary count while the lung lesions and cavitations were examined by X-ray at the end of first 2 months of chemotherapy. After intensive-phase treatment, there were 164 (84.5%) cases of smear-negative conversion and 151 (77.9%) cases of total or partial lesion elimination. The rates of smear-negative conversion (78.3%) and lesion elimination (39.1%) of the PZA-monoresistant patients were similar with the PZA-sensitive group (P > 0.05). However, lung cavitation was more likely to be resolved in PZA-sensitive patients than in the PZA-patients (X2 = 9.623, P = 0.002). The smear-negative conversion rates were 95.9% for the PZA-sensitive patients and 87.0% for the PZA-monoresistant patients after 6 months of treatment (X2 = 3.461, P = 0.063). Together, our data suggest that PZA-monoresistance contributes to the delay of resolution of the lung cavitations in the Southern China population without affecting the sputum conversion and lesion elimination rates.展开更多
A CuAlCl4 doped metal organic framework, CuAlCl4@MIL-101, was prepared by introducing CuAlCl4 into the pores of MIL-101 for the selective adsorption of CO over N2. The CuAlCl4 molecules were evenly distributed into va...A CuAlCl4 doped metal organic framework, CuAlCl4@MIL-101, was prepared by introducing CuAlCl4 into the pores of MIL-101 for the selective adsorption of CO over N2. The CuAlCl4 molecules were evenly distributed into various pores sizes and did not change the intrinsic structure of the MIL-101. Isotherms for CO and N2 adsorption at 298 K showed that the CO capacity on CuAlCl4@MIL-101 was much higher than that on virgin MIL-101, whereas the N2 capacity decreased. The selectivity for CO over N2 improved from 4.64 to 31.5 at 298 K and 1 bar. The CuAlCl4@MIL-101 adsorbent displayed outstanding CO adsorption stability and the adsorbent could be regenerated by applying a simple vacuum of 4 mmHg.展开更多
文摘This study aimed to explore the influence of pyrazinamide (PZA) monoresistance on the treatment outcome of otherwise drug susceptible tuberculosis (TB). A cohort of 194 TB patients that were infected with strains susceptible to isoniazid (INH), rifampin (RIF) and ethambutol (EMB) were included in a retrospective study at the Guangzhou Chest Hospital. We reported 148 (76.3%) PZA- susceptible TB cases and 46 (23.7%) PZA-monoresistance TB cases identified by the BACTEC MGIT 960 system. All patients were treated with the standard 6 months WHO recommended regimen, which included 2 months of INH + RIF + EMB + PZA in the intensive-phase, and the subsequent 4 months of INH + RIF during continuation-phase. Bacterial burden in the lungs was estimated using sputum smear acid-fast bacillary count while the lung lesions and cavitations were examined by X-ray at the end of first 2 months of chemotherapy. After intensive-phase treatment, there were 164 (84.5%) cases of smear-negative conversion and 151 (77.9%) cases of total or partial lesion elimination. The rates of smear-negative conversion (78.3%) and lesion elimination (39.1%) of the PZA-monoresistant patients were similar with the PZA-sensitive group (P > 0.05). However, lung cavitation was more likely to be resolved in PZA-sensitive patients than in the PZA-patients (X2 = 9.623, P = 0.002). The smear-negative conversion rates were 95.9% for the PZA-sensitive patients and 87.0% for the PZA-monoresistant patients after 6 months of treatment (X2 = 3.461, P = 0.063). Together, our data suggest that PZA-monoresistance contributes to the delay of resolution of the lung cavitations in the Southern China population without affecting the sputum conversion and lesion elimination rates.
文摘A CuAlCl4 doped metal organic framework, CuAlCl4@MIL-101, was prepared by introducing CuAlCl4 into the pores of MIL-101 for the selective adsorption of CO over N2. The CuAlCl4 molecules were evenly distributed into various pores sizes and did not change the intrinsic structure of the MIL-101. Isotherms for CO and N2 adsorption at 298 K showed that the CO capacity on CuAlCl4@MIL-101 was much higher than that on virgin MIL-101, whereas the N2 capacity decreased. The selectivity for CO over N2 improved from 4.64 to 31.5 at 298 K and 1 bar. The CuAlCl4@MIL-101 adsorbent displayed outstanding CO adsorption stability and the adsorbent could be regenerated by applying a simple vacuum of 4 mmHg.
